Pharmacological Efficacy of Ginseng against Respiratory Tract Infections

Respiratory tract infections are underestimated, as they are mild and generally not incapacitating. In clinical medicine, however, these infections are considered a prevalent problem. By 2030, the third most comprehensive reason for death worldwide will be chronic obstructive pulmonary disease (COPD...

Full description

Bibliographic Details
Main Authors: Abdulrhman Alsayari, Abdullatif Bin Muhsinah, Dalia Almaghaslah, Sivakumar Annadurai, Shadma Wahab
Format: Article
Language:English
Published: MDPI AG 2021-07-01
Series:Molecules
Subjects:
Online Access:https://www.mdpi.com/1420-3049/26/13/4095
id doaj-19e490afe3d942918920369fc9e16e6f
record_format Article
spelling doaj-19e490afe3d942918920369fc9e16e6f2021-07-15T15:43:04ZengMDPI AGMolecules1420-30492021-07-01264095409510.3390/molecules26134095Pharmacological Efficacy of Ginseng against Respiratory Tract InfectionsAbdulrhman Alsayari0Abdullatif Bin Muhsinah1Dalia Almaghaslah2Sivakumar Annadurai3Shadma Wahab4Department of Pharmacognosy, College of Pharmacy, King Khalid University, Abha 61421, Saudi ArabiaDepartment of Pharmacognosy, College of Pharmacy, King Khalid University, Abha 61421, Saudi ArabiaDepartment of Clinical Pharmacy, College of Pharmacy, King Khalid University, Abha 61421, Saudi ArabiaDepartment of Pharmacognosy, College of Pharmacy, King Khalid University, Abha 61421, Saudi ArabiaDepartment of Pharmacognosy, College of Pharmacy, King Khalid University, Abha 61421, Saudi ArabiaRespiratory tract infections are underestimated, as they are mild and generally not incapacitating. In clinical medicine, however, these infections are considered a prevalent problem. By 2030, the third most comprehensive reason for death worldwide will be chronic obstructive pulmonary disease (COPD), according to the World Health Organization. The current arsenal of anti-inflammatory drugs shows little or no benefits against COPD. For thousands of years, herbal drugs have been used to cure numerous illnesses; they exhibit promising results and enhance physical performance. Ginseng is one such herbal medicine, known to alleviate pro-inflammatory chemokines and cytokines (IL-2, IL-4, IFN-γ, TNF-α, IL-5, IL-6, IL-8) formed by macrophages and epithelial cells. Furthermore, the mechanisms of action of ginsenoside are still not fully understood. Various clinical trials of ginseng have exhibited a reduction of repeated colds and the flu. In this review, ginseng’s structural features, the pathogenicity of microbial infections, and the immunomodulatory, antiviral, and anti-bacterial effects of ginseng were discussed. The focus was on the latest animal studies and human clinical trials that corroborate ginseng’s role as a therapy for treating respiratory tract infections. The article concluded with future directions and significant challenges. This review would be a valuable addition to the knowledge base for researchers in understanding the promising role of ginseng in treating respiratory tract infections. Further analysis needs to be re-focused on clinical trials to study ginseng’s efficacy and safety in treating pathogenic infections and in determining ginseng-drug interactions.https://www.mdpi.com/1420-3049/26/13/4095ginsengrespiratory tract infectionimmuno-modulatory effectscytokinesantiviral activityantibacterial activity
collection DOAJ
language English
format Article
sources DOAJ
author Abdulrhman Alsayari
Abdullatif Bin Muhsinah
Dalia Almaghaslah
Sivakumar Annadurai
Shadma Wahab
spellingShingle Abdulrhman Alsayari
Abdullatif Bin Muhsinah
Dalia Almaghaslah
Sivakumar Annadurai
Shadma Wahab
Pharmacological Efficacy of Ginseng against Respiratory Tract Infections
Molecules
ginseng
respiratory tract infection
immuno-modulatory effects
cytokines
antiviral activity
antibacterial activity
author_facet Abdulrhman Alsayari
Abdullatif Bin Muhsinah
Dalia Almaghaslah
Sivakumar Annadurai
Shadma Wahab
author_sort Abdulrhman Alsayari
title Pharmacological Efficacy of Ginseng against Respiratory Tract Infections
title_short Pharmacological Efficacy of Ginseng against Respiratory Tract Infections
title_full Pharmacological Efficacy of Ginseng against Respiratory Tract Infections
title_fullStr Pharmacological Efficacy of Ginseng against Respiratory Tract Infections
title_full_unstemmed Pharmacological Efficacy of Ginseng against Respiratory Tract Infections
title_sort pharmacological efficacy of ginseng against respiratory tract infections
publisher MDPI AG
series Molecules
issn 1420-3049
publishDate 2021-07-01
description Respiratory tract infections are underestimated, as they are mild and generally not incapacitating. In clinical medicine, however, these infections are considered a prevalent problem. By 2030, the third most comprehensive reason for death worldwide will be chronic obstructive pulmonary disease (COPD), according to the World Health Organization. The current arsenal of anti-inflammatory drugs shows little or no benefits against COPD. For thousands of years, herbal drugs have been used to cure numerous illnesses; they exhibit promising results and enhance physical performance. Ginseng is one such herbal medicine, known to alleviate pro-inflammatory chemokines and cytokines (IL-2, IL-4, IFN-γ, TNF-α, IL-5, IL-6, IL-8) formed by macrophages and epithelial cells. Furthermore, the mechanisms of action of ginsenoside are still not fully understood. Various clinical trials of ginseng have exhibited a reduction of repeated colds and the flu. In this review, ginseng’s structural features, the pathogenicity of microbial infections, and the immunomodulatory, antiviral, and anti-bacterial effects of ginseng were discussed. The focus was on the latest animal studies and human clinical trials that corroborate ginseng’s role as a therapy for treating respiratory tract infections. The article concluded with future directions and significant challenges. This review would be a valuable addition to the knowledge base for researchers in understanding the promising role of ginseng in treating respiratory tract infections. Further analysis needs to be re-focused on clinical trials to study ginseng’s efficacy and safety in treating pathogenic infections and in determining ginseng-drug interactions.
topic ginseng
respiratory tract infection
immuno-modulatory effects
cytokines
antiviral activity
antibacterial activity
url https://www.mdpi.com/1420-3049/26/13/4095
work_keys_str_mv AT abdulrhmanalsayari pharmacologicalefficacyofginsengagainstrespiratorytractinfections
AT abdullatifbinmuhsinah pharmacologicalefficacyofginsengagainstrespiratorytractinfections
AT daliaalmaghaslah pharmacologicalefficacyofginsengagainstrespiratorytractinfections
AT sivakumarannadurai pharmacologicalefficacyofginsengagainstrespiratorytractinfections
AT shadmawahab pharmacologicalefficacyofginsengagainstrespiratorytractinfections
_version_ 1721298718860247040